Valued at USD 19.60 billion in 2024, the inflammatory bowel disease (IBD) treatment market is expected to reach USD 34.15 billion by 2034, growing at a CAGR of 5.71%. Explore the impact of rising IBD prevalence, drug innovation, and expanding therapeutic options across major markets. https://www.expertmarketresearch.com/reports/inflammatory-bowel-disease-treatment-market